In a 68-week trial involving non-diabetic adults with overweight or obesity, the efficacy and safety of weekly subcutaneous semaglutide (2.4mg) and once-daily subcutaneous liraglutide (3.0mg) were compared [10]
For a broader look at how these medications support weight management, How GLP-1 Actually Works for Weight Loss explains the appetite and metabolism connection in simple terms
While I understand that this action may concern some people, the risk of not acting is far greater
Manufactured by Novo Nordisk, Ozempic, which contains semaglutide, works by mimicking a natural hormone, GLP-1, which increases insulin release and decreases appetite, aiding in weight loss, similar to drugs containing mdl
Infect Immun (2004) 72(3):13916